I noted those from a quick read of the update this morning, especially the expenses.
It is a game of patience, but I think the (highly capable) management will continue to extract synergies out of BrighTree, which seems to be bedding down well in the early going. So I am not overly concerned.
Ann: ResMed Announces Results for the Second Qtr of FY 2017, page-8
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$38.64 |
Change
0.530(1.39%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $38.50 | $38.74 | $38.25 | $12.26M | 318.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 367 | $38.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $38.64 | 72 | 4 |
View Market Depth
| Last trade - 11.20am 28/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
